Wegovy price cut: what it actually means if you're paying privately

What actually changed when price-cut stories appeared

The Wegovy price headlines in 2025 were largely about Novo Nordisk adjusting its UK wholesale pricing, not about private patients suddenly paying less at checkout. Eli Lilly made a more dramatic move in the same period, raising Mounjaro's UK list price substantially from September 2025 (the highest dose rose from roughly £122 to around £330 per four-week pen) which changed how Wegovy sat in the market relative to its main competitor. Neither manufacturer controls what private services charge patients. The gap between list price and patient price reflects the pharmacy's costs: dispensing, clinical oversight, prescribing, delivery, and aftercare.

So if a headline announced a Wegovy price cut and your quote from a private service didn't drop accordingly, that isn't a trick. Wholesale adjustments and patient-facing prices are separate things. Our breakdown of the Novo Nordisk Wegovy price changes goes further into what the manufacturer actually announced and what it means in practice, and our overview of Ozempic and Wegovy price cuts puts those announcements in the broader context of how both medicines have been repriced.

The honest picture: UK private Wegovy treatment typically costs somewhere in the range of £149 to £375 per month depending on dose and provider, based on widely reported figures. Those ranges have shifted as supply improved and competition increased, but they have not collapsed to commodity-level prices, and they shouldn't. If you want to understand what a specific point in that range looks like, our page on what the 1 mg Wegovy dose costs is a useful reference for mid-treatment pricing. A fuller look at Wegovy pricing in the UK covers the full dose-by-dose context.

What headline prices often leave out, and why that matters to your decision

A low monthly figure is only meaningful once you know what it covers. Many providers charge separately for the consultation, the prescription, and delivery. Some require you to pay for aftercare calls or dose-review support on top of the medicine cost. A quoted price of, say, £149 that excludes a £30 consultation and £10 delivery becomes £189 before you've had a single injection.

For a prescription medicine taken long-term, the ongoing relationship with your clinical team is part of the treatment. Dose adjustments, side-effect support, and the review before your next pen is dispatched are not optional extras, they're clinical safeguards. When you strip those out to produce a competitive headline number, you're not comparing like with like. Our guide to the full cost of Wegovy treatment breaks this down clearly so you can compare providers on equal terms.

There's a common assumption that if you shop around long enough you'll find Wegovy at a dramatically lower price from a legitimate source. In practice, below a certain floor, supply provenance becomes the real variable, not the pharmacy's efficiency. That's worth sitting with before you enter a card number anywhere.

Where nume stands on price, plainly stated

nume is deliberately not the cheapest Wegovy provider in the UK. That's a choice, not an oversight. One price covers the consultation, the prescription fee, the medicine, free next-working-day DPD delivery in plain packaging, and seven-day aftercare. Nothing is itemised separately, nothing is added at checkout, and there are no ongoing subscription charges to remember to cancel. You can see current treatment pricing on our treatment page.

What that price buys beyond the pen: a GPhC-registered Independent Prescriber reads your consultation the same day. If you're transferring from another provider or moving to a higher dose, you'll be asked for evidence as part of our clinical process. Our clinical approach and the team behind it, including our clinical lead, are on the site if you want to read about who's reviewing your case. You can also verify our pharmacy on the GPhC register directly at registration number 9012878.

We don't run discount codes, vouchers, or promotional pricing for prescription medicines. If you see a code promising reduced-price Wegovy from any provider, that's a prompt to check the seller's GPhC registration before you go further, not a sign you've found a deal.

Why 'cheapest' is the wrong test for a prescription medicine

The MHRA has documented large seizures of counterfeit weight-loss pens sold online, including fake pens found to contain insulin rather than semaglutide. For Wegovy specifically, a medicine you're injecting weekly, the question of whether the pen in your hand is what it says it is matters more than the saving per month. The MHRA's Yellow Card scheme lets you report both side effects and suspect sellers if something doesn't seem right.

NHS England's guidance on weight-management injections is clear that these medicines should be used within a clinically supervised pathway. That supervision (regular review, prescriber availability, a functioning aftercare channel) is what separates a treatment from a transaction. The metric that keeps you safe isn't the monthly fee; it's whether your clinical team is reachable, qualified, and reviewing your progress before each pen is dispensed.

If you'd like to explore whether Wegovy is right for you and how it works as a treatment, or compare it with other options, our weight-loss treatment overview is a good starting point. Or go straight to a free consultation, no commitment, no upfront payment, reviewed the same day.